The neuro-rehabilitation and the use of Zinc on patients with the genetic disease Spinocerebellar ataxia type 2 (SCA2), will improve important clinical, biochemical and neuro-physiological limits, and may alter the evolution of the disease in the mid and long term and thus improve the quality of life of patients.<br />
Read More